María Dolores Fellner

Dr. María Dolores Fellner


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Papillomavirus Research
Verified
Journal Article
Open access
JGJoaquín Víctor González
Joaquín Víctor González
GDGerardo Daniel Deluca
Gerardo Daniel Deluca
RCRita Mariel Correa
Rita Mariel Correa
DLDomingo Javier Liotta
Domingo Javier Liotta
JBJorge Alejandro Basiletti
Jorge Alejandro Basiletti
MPMaría Alejandra Picconi
María Alejandra Picconi
• HPV16/18 decreased by >93% in vaccinated sexually active Argentine girls. • Detected reduction of HPV31 and 45 would add to the success of immunization. • No genotype replacement was observed. • First HPV vaccination monitoring data reported from a Latin American country.

28 April 2021 in Genes
Verified
Journal Article
Open access
PDF file
MFMaría Dolores Fellner
María Dolores Fellner
RBRomina Bonaventura
Romina Bonaventura
JBJorge Basiletti
Jorge Basiletti
MAMartín Avaro
Martín Avaro
EBEstefanía Benedetti
Estefanía Benedetti
EBElsa G. Baumeister
Elsa G. Baumeister
Our aim was to evaluate the analytical and clinical performance of the SARS-CoV-2 molecular detection kits used in Argentina. Nine real-time reverse-transcription polymerase chain reaction (RT-qPCR) and three reverse-transcription loop-mediated isothermal amplification (RT-LAMP) assays were evaluated using the World Health Organization (WHO) recommended test as reference method. A secondary standard calibrated for the E, N and RdRp genes against the Pan American Health Organization—World Health Organization—International Standard was used to calculate the limit of detection (LoD). A panel of artificial clinical samples, 32 positive and 30 negative for SARS-CoV-2, were analyzed to estimate the kappa concordance (κ) and the diagnostic performance. Differences among the LoD values for the target genes amplified by each kit were >1 log copies/reaction. The κ for the RT-qPCR kits was greater than 0.9, whereas that for the RT-LAMP assays ranged from 0.75 to 0.93. The clinical performance of RT-qPCR kits showed 100% specificity and high sensitivity, although with variations according to the gene analyzed. The E and N genes provided greater clinical sensitivity, whereas the RdRp gene increased the clinical specificity. The RT-LAMP assays revealed a variable diagnostic performance. The information provided can be useful to choose the most appropriate diagnostic test and may contribute to the establishment of a consensus in the diagnosis of SARS-CoV-2 in Argentina and the region.